Trial Profile
A Multi-Center, Retrospective Study Assessing the Effectiveness of the Vedolizumab in Pediatric Inflammatory Bowel Disease (IBD) Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- 27 Feb 2018 New trial record